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A B S T R A C T
Recent European regulations require safety assessments of food enzymes (FE) before their commercialization. FE
are mainly produced by micro-organisms, whose viable strains nor associated DNA can be present in the final
products. Currently, no strategy targeting such impurities exists in enforcement laboratories. Therefore, a
generic strategy of first line screening was developed to detect and identify, through PCR amplification and
sequencing of the 16S-rRNA gene, the potential presence of FE producing bacteria in FE preparations. First, the
specificity was verified using all microbial species reported to produce FE. Second, an in-house database, with
16S reference sequences from bacteria producing FE, was constructed for their fast identification through blast
analysis. Third, the sensitivity was assessed on a spiked FE preparation. Finally, the applicability was verified
using commercial FE preparations. Using straightforward PCR amplifications, Sanger sequencing and blast
analysis, the proposed strategy was demonstrated to be convenient for implementation in enforcement labora-
tories.
1. Introduction
In the food and feed industry, microbial strains are increasingly
being used to produce additives, flavourings and enzymes. Among these
microbial strains, most of them are often genetically modified
(Raveendran et al., 2018; Singh, Kumar, Mittal, & Kumar, 2016). In the
particular case of food enzymes (FE), products are placed on the market
under the form of FE preparations, containing a blend of a single or
multiple FE's combined with additional substances (i.e., additives, di-
luents, preservatives and stabilizers) for their stabilization and con-
servation (European Parliament and Council of the European Union,
2008; Pariza & Johnson, 2001; West-Barnette & Srinivasan, 2013).
Since 1971, FE are evaluated worldwide on a voluntary basis by the
Joint FAO/WHO Expert Committee on Food Additives (JECFA) (JEFCA,
2006; Spök, 2006). FE are mostly regulated as food additives or as
processing aids, e.g. in the United States of America, Australia and
Canada (Magnuson et al., 2013). Before 2008, regulations on FE pre-
parations existed only at the national level in a few member states
within the European Union (EU), namely in France (Cerutti, Boudot,
Bournigal, & Rousseau, 2006) and in Denmark (Regulation (EU) 2015/
2283). In light of the EU decision to harmonize regulations related to
the commercialization of FE preparations, the EC/1331/2008, EC/
1332/2008 and EC/1333/2008 regulations were delivered in 2008
(European Parliament and Council, 2008; European Parliament and
Council of the European Union, 2008; European Parliament and the
Council of the European Union, 2008). The first regulation, EC 1331/
2088, establishing a common authorization procedure for food ad-
ditives, FE and food flavourings. The second regulation, EC 1332/2008,
harmonizes the rules on enzymes used in food in the EU and requires
the submission of applications for authorization. The last regulation, EC
1333/2008, harmonizes the use of food additives. Additionally, the FE's
Invertase and Lysozyme, also used as food additive, were already
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submitted to the commission regulation (EU) No 231/2012 (COMMIS-
SION REGULATION (EU) No 231/2012, 2012). Following the regulation
EC/1332/2008, 304 FE dossiers have been submitted between 2011
and 2015 to the EU Commission for their safety evaluation by the
European Food Safety Authority (EFSA) (Anadón et al., 2009; European
Commission, 2016). Although a list of authorized FE for the EU market
will be elaborated, only national regulations are followed in the
meantime.
Currently, the quality control of commercialized FE preparations is,
to our knowledge, under the responsibility of the FE manufacturers
themselves in the EU as well as in the rest of the world (Spök, 2006;
West-Barnette & Srinivasan, 2013). It is therefore assumed that the
company that releases the final product on the market, has verified the
criteria requirements regarding its purity. However, accidental con-
taminations still occur. In particular in the EU food and feed markets,
the presence of such contaminants has already been reported in com-
mercialized fermentation products. For instance, in 2013, a high level
of chloramphenicol, an antibiotic for which a zero tolerance is applied
in the EU, was first detected in xylanase and afterwards also in other FE
preparations (RASFF 2013.1017) (RASFF portal; Standing Committee
on the Food Chain and Animal Health, 2005). Similarly, in 2014, a
microbiological contamination was demonstrated by the presence of a
genetically modified Bacillus subtilis strain, used to produce vitamin B2,
in a vitamin B2 feed additive powder imported from China (Barbau-
piednoir, De Keersmaecker, Delvoye, et al., 2015; Paracchini et al.,
2017) (RASFF 2014.1219, RASFF 2018.2755) (RASFF portal). These
findings support the potential presence of contaminants in microbial
fermented food and feed products, such as FE, despite the purity ver-
ifications by the producing companies. They also emphasize the need
for appropriate detection methods targeting impurities in FE prepara-
tions at the enforcement laboratories level. However, to the best of our
knowledge, no strategy for the detection of such potential contaminants
in FE preparations currently exists in the enforcement laboratories
worldwide, including in the EU.
Among the potential impurities, the presence of producing organ-
isms can be considered as crucial in enzymes, flavourings and additives.
For feed additives, the guidance following regulation (EC) No 1831/
2003 clearly states that the production strain, including both viable
strains and/or their corresponding DNA, must be absent in the final
feed additive product (Rychen et al., 2018). For food enzymes, the
absence of the production strain or its DNA must be proven
(Commission of the European Communities, 1991). Clarifications re-
garding the characterization of FE producing microorganisms have
been provided in an EFSA statement (Pariza & Johnson, 2001). Re-
garding public health concerns, the presence of producer micro-or-
ganisms is particularly critic if it concerns a genetically modified mi-
crobial strain. This because they are frequently harboring antimicrobial
resistance genes as selection markers, that could be acquired via hor-
izontal transfer by pathogens and gut microbiota (Rozwandowicz et al.,
2018; Xiong et al., 2018). Therefore, the identification of the potential
presence of FE producing micro-organisms or their DNA represents an
important first line screening strategy that could be used by enforce-
ment laboratories in order to know if further analyses would be needed
to confirm the suspected accidental contamination.
In this context, we developed a first line generic screening strategy
allowing to both detect and identify FE producing bacteria. This
strategy is based on an available PCR method specific to the 16S-rRNA
gene region, described in several studies as a molecular marker al-
lowing bacterial phylogenetic classifications, and the identification of
bacteria by sequencing (Dorn-In, Bassitta, Schwaiger, Bauer, & Hölzel,
2015; Srinivasan et al., 2015). Firstly, the potential presence of FE
producing bacterial strains is screened by a PCR amplification targeting
the V3–V4 regions of the 16S-rRNA gene (Dorn-In et al., 2015). Sec-
ondly, the generated amplicons are sequenced by Sanger sequencing.
The generated sequences are then identified down to the genus and/or
species level using an in-house 16S-rRNA gene database, developed and
curated in this study. The performance of the proposed generic strategy
of first line screening was assessed. To this end, the specificity was
tested on all FE producing microbial strains mentioned in the list of 304
FE dossiers submitted to EFSA. Moreover, the robustness of the in-house
database, containing all available 16S-rRNA gene region sequences
from FE producing micro-organisms extracted from NCBI, was assessed
through phylogenetic analyses. Using a FE preparation that was artifi-
cially contaminated by a FE producing bacteria, the sensitivity was
evaluated. In addition, to illustrate the applicability, commercial FE
preparations were analysed using our proposed generic strategy.
2. Materials and methods
2.1. Microbial strains
All wild type (WT) species corresponding to the bacteria, fungi and
yeast strains mentioned as FE producing micro-organisms in the list of
304 FE dossiers submitted to EFSA (European Commission, 2016) were
collected. Chryseobacterium proteolyticum was not collected as it has not
been published under the rules of the International Code of Nomen-
clature of Bacteria, which means this species has not been deposited in
a recognized culture collection. Information regarding the strain
number, batch number, species origin and culture conditions are pro-
vided in Table 1. All collected strains were cultured according to the
culture collection recommendations on specific growth media and at
optimal temperatures.
2.2. DNA extraction and concentration
DNA was extracted from the cultured pure strains listed in Table 1,
using the Quick-DNA™ Fungal/Bacterial Miniprep Kit (ZYMO research),
according to the manufacturer's instructions. The DNA extraction of the
FE matrices used for the applicability evaluation (see Section 2.5) was
performed using the NucleoSpin® Food kit (Macherrey-Nagel) ac-
cording to the manufacturer's instructions. DNA extraction of Glycine
max and Oryza sativa was carried out as previously described (Fraiture
et al., 2014). Using the Qubit 4.0 Fluorometer, the DNA concentration
was measured with the dsDNA Broad range (BR) Assay Kit (Life Tech-
nologies) according to manufacturer's instructions.
2.3. PCR amplification of 16S-rRNA gene region and Sanger sequencing
For each PCR reaction, a standard 25 μl reaction volume was ap-
plied containing 1× mastermix, 250 nM of each primer (335-F:
5′-TAATACGACTCACTATAGGCADACTCCTACGGGAGGC-3; 796-R:
5′-TATTTAGGTGACACTATA ATCCTGTTTGMTMCCCVCRC-3′, with T7
and SP6 primer (underlined) recognition sites respectively added to the
5′ end for down-stream sequencing purposes) (Dorn-In et al., 2015) and
5 μl of DNA (2 ng/μl), according to the manufacturer's instructions from
the KAPA Taq EXtra HotStart ReadyMix PCR kit (KAPA Biosystems).
The PCR program consisted of an initial denaturation of 3min at 95 °C
followed by 35 amplification cycles of 30 s at 95 °C, 30 s at 50 °C and
1min at 72 °C, and a final extension of 1min at 72 °C. The run was
performed on a Swift Aeris Thermal Cycler (ESCO). For each assay, a
non-template control (NTC) and negative controls, consisting out of
human (TaqMan™ Control Genomic DNA, ThermoFisher), plant (Gly-
cine max and Oryza sativa) and the fungal and yeast species mentioned
in Table 1, were included. The final PCR products were analysed by
electrophoresis using the D1000 screentapes and reagents on a Tapes-
tation 4200 device (Agilent, Belgium), according to manufacturer's in-
structions, in order to visualize the profiles of the generated amplicons.
For each sample, the generated amplicon was then purified using the
ExoSAP-IT® PCR Product Clean-up (Thermo Fisher). In case of multiple
amplicons, the final PCR product was separated by electrophoresis on a
1% agarose gel (INVITROGEN, CA, USA) (100 V, 400mA, 40min).
Amplicons of interest were excised from the gel and purified using the
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Table 1
Overview of all FE producing micro-organisms mentioned in the list of 304 FE dossiers submitted to EFSA that were collected in this study. For each organism,
representative strains were selected and the strain number, batch number, name of the original collection (origin) and culturing conditions used are indicated.
Presence of the organism in the QPS (qualified presumption of safety) list of EFSA is also indicated.
Kingdom Genus Species Origin Culturing conditions QPS
Strain number Collection Batch number Medium Temperature
Bacteria Arthrobacter ramosus LMG 17309 BCCM 17309 LYO 04/13 NA 28 °C No
Bacillus licheniformis MB 392 ILVO NA 30–37 °C Yes
Bacillus subtillis MB 4578 ILVO NA 30–37 °C Yes
Bacillus circulans MB 367 ILVO NA 30–37 °C No
Bacillus pumilus QA 55 ILVO NA 30–37 °C Yes
Bacillus amyloliquefaciens LMG 9814 BCCM 09814 LYO 06/09 NA 30 °C Yes
Bacillus flexus LMG 11155 BCCM 11155 LYO 09/00 NA 30 °C Yes
Cellulosimicrobium cellulans LMG 16121 BCCM 16121 LYO 06/95 NA 28 °C No
Chryseobacterium proteolyticuma / / / / / No
Corynebacterium glutamicum LMG 3652 BCCM 03652 LYO 05/11 NA 30 °C No
Escherichia coli MB 1068 ILVO NA 30–37 °C No
Geobacillus stearothermophilus MB 394 ILVO NA 55 °C No
Geobacillus pallidus MB 401 ILVO NA 55 °C No
Geobacillus caldoproteolyticus DSM 15730 DSMZ DSM 15730-0703-001 Caso agar 55 °C No
Klebsiella pneumoniae MB 4414 ILVO NA 30–37 °C No
Lactobacillus fermentum LMG 6902 BCCM 06902 LYO 03/14 MRS 37 °C Yes
Lactococcus lactis MB 96 ILVO MRS 30 °C Yes
Leuconostoc citreum LMG 9824 BCCM 09824 LYO 03/05 MRS 30 °C Yes
Microbacterium imperiale LMG 20190 BCCM 20190 LYO 12/11 14 28 °C Yes
Paenibacillus macerans LMG 6324 BCCM 063240 LYO 08/00 14 28 °C No
Paenibacillus alginolyticusa / / / / / No
Protaminobacter rubrum CBS 574.77 CBS 19 (pepton agar) 30 °C No
Pseudomonas fluorescens MB 4440 ILVO NA 28–30 °C No
Pseudomonas amyloderamosab ATCC-21262 ATCC 39531 NA 30 °C No
Pullulanibacillus naganoensis LMG 12887 BCCM 12887 LYO 06/08 232 30 °C No
Streptomyces violaceoruber LMG 7183 BCCM 07183 LYO 03/86 78 28 °C No
Streptomyces murinus LMG 10475 BCCM 10475 LYO 06/03 78 28 °C No
Streptomyces netropsis LMG 5977 BCCM 05977 LYO 03/89 78 28 °C No
Streptomyces mobaraensis DSM 40847 DSMZ DSM 40847-0616-001 Yeast malt extract agar 24 °C No
Streptomyces rubiginosus LMG20268 BCCM 20268 LYO 06/01 78 28 °C No
Fungi Aspergillus oryzae IHEM 25836 BCCM IHEM LY2012-1051 Medium S10 25 °C No
Aspergillus niger IHEM 05296 BCCM IHEM LY2016-0075 Medium S10 25 °C No
Aspergillus niger agg.a / / / / / No
Aspergillus niger macrosporusa / / / / / No
Aspergillus niger awamori IHEM 25485 BCCM IHEM LY2012-0133 Medium S10 25 °C No
Aspergillus fijiensis IHEM 22812 BCCM IHEM LY2012-0198 Medium S10 25 °C No
Aspergillus acidus IHEM 26285 BCCM IHEM LY2014-0334 Medium S10 25 °C No
Aspergillus aculeatus IHEM 05796 BCCM IHEM LY2016-0579 Medium S10 25 °C No
Aspergillus melleus IHEM 25956 BCCM IHEM LY2013-0309 Medium S10 25 °C No
Chaetomium gracile MUCL 053569 BCCM FRT-2011-0283 PDA 25 °C No
Chaetomium erraticuma / / / / / No
Cryphonectria parasitica MUCL 007956 BCCM OIL-2017-0171 MA1 20 °C No
Sporobolomyces singularis MUCL 027849 BCCM FRT-1996-1295 MYA2 24 °C No
Disporotrichum dimorphosporum MUCL 019341 BCCM FRT-1999-0506 MYA2 23 °C No
Boletus edulis MUCL 043104 BCCM FRT-2001-0009 MA2 25 °C No
Fusarium venenatum MUCL 055417 BCCM FRT-2014-0324 PDA 25 °C No
Hansenula polymorpha MUCL 027761 BCCM FRT-2008-0858 MYA2 25 °C No
Humicola insolens MUCL 015010 BCCM FRT-2000-1490 PDA 37 °C No
Kluyveromyces lactis IHEM 02051 BCCM IHEM LY2007-0748 Medium S 25 °C Yes
Leptographium procerum MUCL 008094 BCCM FRT-1999-2437 DYAA 20 °C No
Mucor javanicus IHEM 05212 BCCM IHEM LY2012-1038 Medium S10 25 °C No
Penicillium roqueforti IHEM 20176 BCCM IHEM LY2003-0624 Medium S10 25 °C No
Penicillium camemberti IHEM 06648 BCCM IHEM LY2016-0256 Medium S10 25 °C No
Penicillium multicolor CBS 501.73 CBS MEA 24 °c No
Penicillium citrinium IHEM 26159 BCCM IHEM LY2014-0060 Medium S10 25 °C No
Penicillium decumbens IHEM 05935 BCCM IHEM LY2002-0039 Medium S10 25 °C No
Penicillium chrysogenum IHEM 03414 BCCM IHEM LY2002-0279 Medium S10 25 °C No
Penicillium funiculosum MUCL 014091 BCCM FRT-2000-2027 MYA2 25 °C No
Rhizomucor miehei IHEM 26897 BCCM IHEM LY2016-0179 Medium S10 37 °C No
Rhizopus oryzae IHEM 26078 BCCM IHEM LY2013-0805 Medium S10 25 °C No
Rhizopus niveus ATCC 200757 ATCC 2547375 PDA 25 °C No
Talaromyces pinophilus IHEM 16004 BCCM IHEM LY200-2056 Medium S10 25 °C No
Talaromyces emersonii DSM 2432 DSMZ DSM 2432-0807-001 OAT FLAKE MEDIUM 40 °C No
Trametes hirsute MUCL 030869 BCCM FRT-1996-0924 MA1 20 °C No
Trichoderma reesei IHEM 05651 BCCM IHEM LY2006-0407 Medium S10 25 °C No
Trichoderma citrinoviride IHEM 25858 BCCM IHEM LY2013-0070 Medium S10 25 °C No
Trichoderma viride IHEM 04146 BCCM IHEM LY2002-0631 Medium S10 25 °C No
(continued on next page)
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Wizard® SV Gel and PCR Clean-Up System (Promega, WI, USA). The
purified PCR products/excised amplicons were subsequently sequenced
on a Genetic Sequencer 3130XL using the Big Dye Terminator Kit v3.1
(Applied Biosystems).
2.4. Collection of 16S-rRNA gene region sequences to build the in-house
curated database of FE producing bacteria
For the 30 bacterial species indicated as FE producer in the EFSA
(European Commission, 2016) list (see Table 1), all available sequences
from the NCBI 16S RefSeq Nucleotide sequence records database (ac-
cessed February 2018) were collected (O'Leary et al., 2016), resulting in
a total set of 107 reference sequences for 29 species (Table 1). No se-
quence record was available for Pseudomonas amyloderamosa, for which
no representative entry is therefore present in our database. The am-
plicons of 16S-rRNA gene regions targeted by our PCR, using the pri-
mers mentioned in Section 2.3, were afterwards manually extracted
from these sequence records in order to construct a 16S-rRNA gene
region in-house curated database (see Supplementary file I). Own
generated 16S-rRNA sequences during this study were afterwards
added to the in-house database.
2.5. Species identification
The megablast program (Camacho et al., 2009) from the BLAST
suite (v2.8.0) was used to perform species identification employing the
generated amplicon sequences (see Section 2.3) as query, and the entire
in-house 16S-rRNA gene region database (see Section 2.4) as subject
(using default settings). The first BLAST hit (sorted based on e-value)
was considered to represent the FE producing bacteria. A series of ad-
ditional phylogenetic analyses were performed to investigate the value
of using the 16S-rRNA gene as a marker for identification of the FE
producing bacteria. Firstly, for all generated 16S-rRNA gene region
amplicon sequences (see Section 2.3), the forward and reverse se-
quences were assembled into a consensus sequence. All resulting se-
quences were then aligned by Muscle using the MEGA software (version
7.0.18) using the following settings: max Iterations: 100 (all other
settings were left at their default values). Next, model selection (MS),
and tree building (TB) using the best model identified by MS, were
performed with MEGA using the following settings: Gaps/missing data
treatment: Partial deletion (MS+TB), Site coverage cut-off: 50%
(MS+TB), Branch swap filter: very weak (MS), Number of bootstrap
replications: 100 (TB), ML Heuristic Method: Subtree-Pruning-Re-
grafting - Fast (SPR Level 3) (TB). All other settings were left at their
default values. Secondly, the same analysis was performed for the entire
in-house 16S-rRNA gene region database supplemented with all gen-
erated 16S-rRNA gene region amplicon sequences (see Section 2.3). For
both analyses, the resulting bootstrap consensus tree was visualized
using FigTree (version 1.4.3, available at https://github.com/rambaut/
figtree/releases/tag/v1.4.3) employing a midpoint rooting. To reduce
the size of the trees and facilitate their subsequent interpretation, all
terminal branches that represent either the same genus or species were
collapsed, resulting in two interpretations of each tree (Supplementary
files IV and V).
2.6. Sensitivity analysis
The sensitivity of the proposed strategy was tested using the com-
mercialized liquid FE preparation α-amylase (Termamyl®, Novozymes
Corp.) produced by Bacillus licheniformis. This FE preparation was ar-
tificially contaminated with different concentrations of the wild-type
Bacillus licheniformis. More precisely, a single colony of B. licheniformis
(MB 392) was cultured overnight (16 h) at optimal growth conditions
(Table 1, Fig. 2). This fresh culture (10 μl) was diluted in 10ml fresh
BHI medium and grown to an OD600 of 0.7 to constitute the mother
dilution (D-0), that was used to perform a 10-fold serial dilution until D-
8. 100 μl of each dilution (D-0 to D-8) was plated on NA medium for the
enumeration of colonies (grown overnight at 37 °C) (Fig. 2A). 200 μl of
each dilution (D-0 to D-8) was mixed with 200 μl of the commercialized
FE, α-amylase, and 200 μl of each mixture was also plated on NA
medium for enumeration (grown overnight at 37 °C) (Fig. 2). The plates
of the D-0 to D-8 dilutions, from both the pure culture and the artifi-
cially spiked FE preparation samples, gave similar number of colonies,
demonstrating that the used FE preparation seems to have no impact on
the growth of Bacillus licheniformis.
From both the non-spiked and the spiked D-0 to D-6 solutions,
200 μl was used for DNA extraction using the NucleoSpin® Food kit
(Macherrey-Nagel), according to the manufacturer's instructions with
the addition of an initial beating step of 2 ∗ 2min at 5000 rpm (MiniLys,
Bertin Instruments) (see Section 2.2) in order to analyse the sensitivity
of the proposed generic strategy of first line screening. The estimated
colony numbers used for each PCR amplification are indicated in
Fig. 2C. As a control, the proposed generic strategy of first line
screening was also applied on an isolated colony, obtained from the
previous plating of the D-0 to D-8 dilutions (see Fig. 2A).
2.7. Applicability assessment
The applicability of the proposed strategy was verified using six
commercially available FE preparations: (1) papain (Vitalingo), from
Papaya, under a solid form; (2) lactase (Lactose-OK) produced by
Aspergillus oryzae, under a solid form; (3) microbial rennet (Lactoferm-
Brouwland), produced by Rhizomucor miehei, under a solid form; (4)
flour treatment agent (Molen ‘de père’), from an unknown origin, under
a solid form; (5) α-amylase (Dextzyme HT, The Alchemist's Pantry),
produced by Bacillus licheniformis, under a solid form; (6) neutral pro-
tease (Pureferm, The Alchemist's Pantry), produced by Bacillus subtilis,
under a solid form (Fig. 3A). Of all these FE preparations DNA was
Table 1 (continued)
Kingdom Genus Species Origin Culturing conditions QPS
Strain number Collection Batch number Medium Temperature
Yeasts Candida cylindracea MUCL 041387 BCCM FRT-1998-2273 DYPA 25 °C Yes
Candida rugose IHEM 01894 BCCM IHEM LY2002-0071 Medium S 25 °C No
Pichia pastori MUCL 027793 BCCM FRT-2015-0116 MYA2 24 °C No
Saccharomyces cerevisiae IHEM 25104 BCCM IHEM LY2011-0436 Medium S 25 °C Yes
Collections: BCCM=Belgian Coordinated Collections of Micro-organisms; ILVO=Research Institute for Agriculture, Fisheries and Food; DSMZ=Deutsche
Sammlung von Mikroorganismen und Zellkulturen GmbH.
Medium: BHI= brain heart infusion; DYAA=dextrose 1% yeast extract asparagine agar; DYPA=dextrose yeast extract peptone water; MA=malt agar;
MEA=malt extract agar; MRS=De Man, Rogosa and Sharpe; MYA2=malt 2% yeast extract agar; NA=nutrient agar; PDA=potato dextrose agar;
S10= Sabouraud diluted; 14=Tryptone soy agar; 78=GYM STREPTOMYCES MEDIUM; 232=Trypticase Soy Broth supplemented with 1% soluble starch, pH 5.5.
a Species that were unavailable in the consulted collections.
b Bacterial species for which no sequence information was available in the 16S RefSeq Nucleotide sequence records (NCBI).
M. Deckers, et al. Food Chemistry 305 (2020) 125431
4
extracted using the NucleoSpin® Food kit (Macherrey-Nagel) according
to the manufacturer's instructions with the addition of an initial beating
step of 2 ∗ 2min at 5000 rpm (MiniLys, Bertin Instruments) in order to
verify the applicability of the proposed generic strategy of first line
screening.
Additionally, for the α-amylase product (Dextzyme HT, The
Alchemist's Pantry) and the neutral protease product (Pureferm, The
Alchemist's Pantry) a liquid culture, composed of 1 g of FE powder and
5ml of BHI, was grown overnight at 37 °C. This mixture was plated on
NA medium (grown overnight at 37 °C) and isolated colonies were
submitted to the proposed generic strategy of first line screening.
3. Results and discussion
3.1. Overview of FE producing micro-organisms
Within the list of 304 FE dossiers submitted to EFSA (European
Commission, 2016) 53%, 2% and 32% are produced by fungi, yeasts
and bacteria, respectively (Table 1). The remaining 13% are extracted
from animals or plants. In total, 71 different species of micro-organisms
are mentioned for the production of FE. Within the FE produced by
bacteria, the majority is produced by B. subtilis (23.8%) and B. licheni-
formis (21.6%). Besides WT strains, genetically modified strains are
often used for the production of FE, representing 50.5% of all the
mentioned bacterial FE production strains.
Of the 71 different species, only 14 (19.7%) have been added by
EFSA to the qualified presumption of safety (QPS) list of biological
agents (Ricci et al., 2017). All other species could not be granted the
QPS status because they produce mycotoxins, are linked to human
disease, lack a sufficient body of knowledge on a history of safe use, or
other reasons.
3.2. Specificity of the 16S strategy to detect and identify FE producing
micro-organisms
The use of conventional PCR methods, specifically targeting the
V3–V4 16S-rRNA gene regions, followed by sequencing is a well-known
approach for the detection and identification of bacterial species (Dorn-
In et al., 2015; Lebonah et al., 2014). However, in this study such an
approach is tested for the first time to systematically detect and identify
FE producing bacterial strains. In order to test the specificity of the
proposed generic strategy of first line screening, all microbial strains
used to produce FE, as mentioned in in the list of 304 FE dossiers
submitted to EFSA, were collected and analysed, including 28 bacterial
species, 34 fungal species and 4 yeast species. As expected, the DNA
from all tested bacterial strains was positively amplified by the con-
ventional PCR method. Whereas, no PCR amplification was obtained for
all tested fungal and yeast strains, nor for the plant samples (Glycine
max and Oryza sativa) and the human sample that were integrated in
the analysis to complete the specificity study (Table 2A, Supplementary
files II and III). More precisely, a single amplicon of the expected size
(390–420 bp) was observed for the DNA of each tested bacterial strain,
except for Paenibacillus macerans (Supplementary file II) for which 5
amplicons were observed, including four with a weak signal intensity,
that were discarded for further analysis, and one at the expected size
(416 bp) with a strong signal intensity that was selected for subsequent
analysis (Supplementary file II). These results confirm the ability of the
conventional PCR to specifically amplify the bacterial 16S-rRNA gene
region (i.e. a signal is obtained for all bacterial strains but not for other
kingdoms) (Dorn-In et al., 2015).
All obtained amplicons from the conventional PCR amplification
were sequenced using the Sanger technology, after which the identity of
each generated sequence was obtained by blasting against an in-house
16S-rRNA gene region database consisting of all available 16S-rRNA
gene region sequences belonging to the FE producing bacterial strains
from the NCBI 16S RefSeq Nucleotide sequence records database. To
Table 2
Assessment of the proposed new generic strategy to detect contaminations of FE
producing bacteria in FE preparations.
(A) Summarized results from the 16S-rRNA gene PCR-based sequencing, ap-
plied on the FE producing micro-organisms mentioned in Table 1. Plants and
human samples were used as negative controls.
(B) Overview of all collected bacterial strains with their generated 16S-rRNA
gene amplicon using the new generic strategy. For each strain, the generated
amplicon sequence was analysed by blasting against an in-house curated 16S-
rRNA gene database containing 16S-rRNA gene sequence information for all FE
producing bacterial strains, for which the correct species was always assigned
as first hit. For each bacterial strain, the range in percent identity of hits to the
correct species is indicated in the column “Percent identity range for the ex-
pected correct species”. The first hit and its identity to an incorrect species, is
also indicated.
A
16S-rRNA gene region amplification
Bacteria (28) 28/28
Fungi/yeast (34) 0/34
Yeast (4) 0/4
Plants (2) 0/2
Human (1) 0/1
FE producing bacteria
Generated 16S rRNA gene region amplicon with the developed PCR method from this
study
Size (bp)
BLAST against curated in-house 16S rRNA gene region database consisting out of FE
producing strains
Percent identity range for the expected correct speciesb
First hit, and its percent identity, to an incorrect species
Arthrobacter
ramosus
AGCAGTGGGGAATATTGCACAATGGGCGGAAGCCTGATGCAGCGACGCCGCGTGAG
GGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGTAGGGAAGAAGCGAAAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTATCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGTTTGTCGCGTC
TGCTGTGAAAGACCGGGGCTCAACTCCGGTTCTGCAGTGGGTACGGGCAGACTAGAG
TGATGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGA
GGAACACCGATGGCGAAGGCAGGTCTCTGGGCATTAACTGACGCTGAGGAGCGAAA
396
100%1
Microbacterium imperiale, 95%
Bacillus
licheniformis
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGTTTTCGGATCGTAAAACTCTGTTGTTAGGGAAGAACAAGTACCGTTCGA
ATAGGGCGGTACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGC
AGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCG
CGCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCCCGGCTCAACCGGGGAGGGTCAT
TGGAAACTGGGGAACTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGT
GAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAA
CTGACGCTGAGGCGCGAAA
417
100%3–99%1
Bacillus subtilis, 99%
Bacillus
subtillis
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGAAGAACAAGTACCGTTCGA
ATAGGGCGGTACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGC
AGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGGGCT
CGCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCCCGGCTCAACCGGGGAGGGTCAT
TGGAAACTGGGGAACTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGT
GAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAA
CTGACGCTGAGGAGCGAAA
417
100%7–99%1
Bacillus amyloliquefaciens, 99%
Bacillus
circulans
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AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGTTTTCGGATCGTAAAACTCTGTTGTTAGGGAAGAACAAGTACAAGAGTA
ACTGCTTGTACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGCA
GCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCGC
GCAGGCGGTCCTTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCATT
GGAAACTGGGGGACTTGAGTGCAGAAGAGAAGAGTGGAATTCCACGTGTAGCGGTG
AAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTTTGGTCTGTAAC
TGACGCTGAGGCGCGAAA
416
100%3–99%2
Bacillus flexus, 97%
Bacillus
pumilus
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGAAGAACAAGTGCGAGAGTA
ACTGCTCGCACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGCA
GCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGGGCTC
GCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCCCGGCTCAACCGGGGAGGGTCATT
GGAAACTGGGAAACTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTG
AAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAAC
TGACGCTGAGGAGCGAAA
416
100%5
Bacillus amyloliquefaciens, 97%
Bacillus
amyloliquefaciens
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGAAGAACAAGTGCCGTTCAA
ATAGGGCGGCACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGC
AGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGGGCT
CGCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCCCGGCTCAACCGGGGAGGGTCAT
TGGAAACTGGGGAACTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGT
GAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAA
CTGACGCTGAGGAGCGAAA
417
100%5
Bacillus subtilis, 99%
Bacillus
flexus
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGCTTTCGGGTCGTAAAACTCTGTTGTTAGGGAAGAACAAGTACAAGAGTA
ACTGCTTGTACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGCA
GCCGCGGTAATACGTAGGTGGCAAGCGTTATCCGGAATTATTGGGCGTAAAGCGCGC
GCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCATT
GGAAACTGGGGAACTTGAGTGCAGAAGAGAAAAGCGGAATTCCACGTGTAGCGGTG
AAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGGCTTTTTGGTCTGTAAC
TGACGCTGAGGCGCGAAA
416
100%2–98%1
Bacillus circulans, 97%
Cellulosimicrobium
cellulans
AGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAG
GGATGAAGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGCAAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGTTTGTCGCGTC
TGGTGTGAAAACTCGAGGCTCAACCTCGAGCTTGCATCGGGTACGGGCAGACTAGAG
TGCGGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGGAATGCGCAGATATCAGGA
GGAACACCGATGGCGAAGGCAGGTCTCTGGGCCGCAACTGACGCTGAGGAGCGAAA
396
100%1–99%2
Microbacterium imperiale, 96%
Chryseobacterium
proteolyticuma
NA
/
/
/
Corynebacterium
glutamicum
AGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCGACGCCGCGTGGG
GGATGACGGCCTTCGGGTTGTAAACTCCTTTCGCTAGGGACGAAGCCTTATGGTGAC
GGTACCTGGAGAAGAAGCACCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAG
GGTGCGAGCGTTGTCCGGAATTACTGGGCGTAAAGAGCTCGTAGGTGGTTTGTCGCG
TCGTCTGTGAAATCCCGGGGCTTAACTTCGGGCGTGCAGGCGATACGGGCATAACTT
GAGTGCTGTAGGGGAGACTGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAG
GAGGAACACCAATGGCGAAGGCAGGTCTCTGGGCAGTAACTGACGCTGAGGAGCG
AAA
399
99%2
Arthrobacter ramosus, 91%
Escherichia
coli
AGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTGTAT
GAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAAGGGAGTAAAGTTA
ATACCTTTGCTCATTGACGTTACCCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGC
AGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC
ACGCAGGCGGTTTGTTAAGTCAGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCA
TCTGATACTGGCAAGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGT
GAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACGAAG
ACTGACGCTCAGGTGCGAAA
416
100%1–99%2
Klebsiella pneumoniae, 95%
Geobacillus
stearothermophilus
AGCAGTAGGGAATCTTCCGCAATGGGCGAAAGCCTGACGGAGCGACGCCGCGTGAG
CGAAGAAGGCCTTCGGGTCGTAAAGCTCTGTTGTGAGGGACGAAGGAGCGCCGTTCG
AAGAGGGCGGCGCGGTGACGGTACCTCACGAGAAAGCCCCGGCTAACTACGTGCCA
GCAGCCGCGGTAATACGTAGGGGGCGAGCGTTGTCCGGAATTATTGGGCGTAAAGC
GCGCGCAGGCGGTCTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGT
CATTGGAAACTGGGGGACTTGAGGGCAGGAGAGGAGAGCGGAATTCCACGTGTAGC
GGTGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGGCTCTCTGGCCT
GCACCTGACGCTGAGGCGCGAAA
417
100%5
Geobacillus caldiproteolyticus, 94%
Geobacillus
pallidus
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAG
CGAAGAAGGTCTTCGGATCGTAAAGCTCTGTTGTCAGGGAAGAACAAGTGCCGTTCG
AACAGGGCGGTACCTTGACGGTACCTGACGAGGAAGCCACGGCTAACTACGTGCCAG
CAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGC
GCGCAGGCGGTTCCTTAAGTCTGATGTGAAATCTCGCGGCTCAACCGCGAGCGGCCA
TTGGAAACTGGGGAACTTGAGTGCAGGAGAGGGGAGCGGAATTCCACGTGTAGCGG
TGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGGCTCTCTGGCCTGTA
ACTGACGCTGAGGCGCGAAA
417
99%1
Geobacillus caldiproteolyticus, 95%
Geobacillus
caldiproteolyticus
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAG
CGAAGAAGGTCTTCGGATTGTAAAGCTCTGTTGTTAGGGAAGAAGAGGTGCCGTTCG
AACAGGGCGGTACCGTGACGGTACCTAACGAGAAAGCCACGGCTAACTACGTGCCAG
CAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGC
GCGCAGGCGGTCTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCA
TTGGAAACTGGGAGACTTGAGTGCAGAAGAGGAGAGCGGAATTCCACGTGTAGCGG
TGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGGCTCTCTGGTCTGTA
ACTGACGCTGAGGCGCGAAA
417
100%2
Bacillus licheniformis, 96%
Klebsiella
pneumoniae
AGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTGTGT
GAAGAAGGCCTTCGGGTTGTAAAGCACTTTCAGTGGGGAGGAAGGCGTTAAGGTTA
ATAACCTTGGCGATTGACGTTACCCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGC
AGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC
ACGCAGGCGGTCTGTCAAGTCGGATGTGAAATCCCCGGGCTTAACCTGGGAACTGCA
TTCGAAACTGGCAGGCTAGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGT
GAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACAAAG
ACTGACGCTCAGGTGCGAAA
416
99%3–98%8
Protaminobacter rubrum, 95%
Lactobacillus
fermentum
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AGCAGTAGGGAATCTTCCACAATGGGCGCAAGCCTGATGGAGCAACACCGCGTGAGT
GAAGAAGGGTTTCGGCTCGTAAAGCTCTGTTGTTAAAGAAGAACACGTATGAGAGTA
ACTGTTCATACGTTGACGGTATTTAACCAGAAAGTCACGGCTAACTACGTGCCAGCA
GCCGCGGTAATACGTAGGTGGCAAGCGTTATCCGGATTTATTGGGCGTAAAGAGAGT
GCAGGCGGTTTTCTAAGTCTGATGTGAAAGCCTTCGGCTTAACCGGAGAAGTGCATC
GGAAACTGGATAACTTGAGTGCAGAAGAGGGTAGTGGAACTCCATGTGTAGCGGTG
GAATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTACCTGGTCTGCAAC
TGACGCTGAGACTCGAAA
416
100%2–98%1
Bacillus pumilus, 88%
Lactococcus
lactis
AGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGT
GAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTG
GAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGTGCCAGC
AGCCGCGGTAATACGTAGGTCCCGAGCGTTGTCCGGATTTATTGGGCGTAAAGCGAG
CGCAGGTGGTTTATTAAGTCTGGTGTAAAAGGCAGTGGCTCAACCATTGTATGCATT
GGAAACTGGTAGACTTGAGTGCAGGAGAGGAGAGTGGAATTCCATGTGTAGCGGTG
AAATGCGTAGATATATGGAGGAACACCGGTGGCGAAAGCGGCTCTCTGGCCTGTAAC
TGACACTGAGGCTCGAAA
416
100%7
Pullulanibacillus naganoensis, 87%
Leuconostoc
citreum
TGCAGTAGGGAATNTTCCACAATGGGCGCAAGCCTGATGGAGCAACGCCGCGTGTGT
GATGAAGGCTTTCGGGTCGTAAAGCACTGTTGTATGGGAAGAAATGCTAAAATAGGG
AATGATTTTAGTTTGACGGTACCATACCAGAAAGGGACGGCTAAATACGTGCCAGCA
GCCGCGGTAATACGTATGTCCCGAGCGTTATCCGGATTTATTGGGCGTAAAGCGAGC
GCAGACGGTTGATTAAGTCTGATGTGAAAGCCCGGAGCTCAACTCCGGAATGGCATT
GGAAACTGGTTAACTTGAGTGTTGTAGAGGTAAGTGGAACTCCATGTGTAGCGGTGG
AATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTTACTGGACAACAACT
GACGTTGAGGCTCGAAA
416
99%1
Lactobacillus fermentum, 84%
Microbacterium
imperiale
AGCAGTGGGGAATATTGCACAATGGGCGGAAGCCTGATGCAGCAACGCCGCGTGAG
GGATGACGGCCTTCGGGTTGTAAACCTCTTTTAGCAGGGAAGAAGCGAGAGTGACGG
TACCTGCAGAAAAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTATCCGGAATTATTGGGCGTAAAGAGCCGTAGGCGGTTTGTCGCGTCT
GCTGTGAAATCCCGAGGCTCAACCTCGGGCCTGCAGTGGGTACGGGCAGACTAGAGT
GCGGTAGGGGAGATTGGAATTCCTGGTGTAGCGGTGGAATGCGCAGATATCAGGAG
GAACACCGATGGCGAAGGCAGATCTCTGGGCCGTAACTGACGCTGAGGAGCGAAA
395
99%1–98%1
Cellulosimicrobium cellulans, 95%
Paenibacillus
macerans
AGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGT
GATGAAGGTTTTCGGATCGTAAAGCTCTGTTGCCAGGGAAGAACGTCTTNTGGAGTA
ACTGCCANGAGAGTGACGGTACCTGAGAAGAAAGCCCCGGCTAACTACGTGCCAGCA
GCCGCGGTAATACGTAGGGGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCGC
GCAGGCGGCTGTTTAAGTCTGGTGTATAATCCTGGGGCTCAACTCCGGGTCGCACTG
GAAACTGGACGGCTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGA
AATGCGTAGAGATGTGGAGGAACACCAGTGGCGAGAGGCGACTCTCTGGGCTGTAA
CTGACGCTGAGGCGCGAAA
416
99%2–93%1–92%1
Paenibacillus alginolyticus, 89%
Paenibacillus
alginolyticusa
NA
/
/
/
Protaminobacter
rubrum
AGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTGTGT
GAAGAAGGCCTTAGGGTTGTAAAGCACTTTCAGCGAGGAGGAAGGGTAGTGTGTTA
ATAGCACATTGCATTGACGTTACTCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGC
AGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC
ACGCAGGCGGTTTGTTAAGTCAGATGTGAAATCCCCGCGCTTAACGTGGGAACTGCA
TTTGAAACTGGCAAGCTAGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGT
GAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACAAAG
ACTGACGCTCAGGTGCGAAA
416
99%3
Klebsiella pneumoniae, 95%
Pseudomonas
fluorescens
AGCAGTGGGGAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGT
GAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCATTAACCTAA
TACGTTAGTGTTTTGACGTTACCGACAGAATAAGCACCGGCTAACTCTGTGCCAGCA
GCCGCGGTAATACAGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCGC
GTAGGTGGTTTGTTAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATT
CAAAACTGACTGACTAGAGTATGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGA
AATGCGTAGATATAGGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTAATACT
GACACTGAGGTGCGAAA
416
100%4–99%1
Klebsiella pneumoniae, 87%
Pseudomonas
amyloderamosa
AGCAGTGGGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCAATGCCGCGTGTGT
GAAGAAGGCCTTCGGGTTGTAAAGCACTTTTATCAGGAGCGAAATACTACCGGCTAA
TATCCGGTGGGGCTGACGGTACCTGAGGAATAAGCACCGGCTAACTTCGTGCCAGCA
GCCGCGGTAATACGAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGTGC
GTAGGCGGTTATTTAAGTCTGTTGTGAAATCCCCGGGCTCAACCTGGGAATGGCAAT
GGATACTGGATAGCTAGAGTGTGATAGAGGATGGTGGAATTCCCGGTGTAGCGGTG
AAATGCGTAGAGATCGGGAGGAACATCAGTGGCGAAGGCGGCCATCTGGATCAACA
CTGACGCTGAGGCACGAAA
416
/
No P. amyloderamosa sequence available in the in-house database.
Klebsiella pneumoniae, 84%
Pullulanibacillus
naganoensis
AGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAG
CGATGAAGGTCTTCGGATCGTAAAGCTCTGTTGTCAGAGAAGAACACGTGATAGAGG
AAATGCTATCACCTTGACGGTATCTGACCAGAAAGCCCCGGCTAACTACGTGCCAGC
AGCCGCGGTAATACGTAGGGGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGCGCG
CGCAGGCGGCTTCTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGAGGGTCAT
TGGAAACTGGGGAGCTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGT
GAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAAGCGGCTCTCTGGTCTGTAA
CTGACGCTGAGGCGCGAAA
416
100%1
Bacillus pumilus, 94%
Streptomyces
violaceoruber
AGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAG
GGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTC
GGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAG
TTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAA
396
100%4
Streptomyces mobaraensis, 99%
Streptomyces
murinus
AGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAG
GGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCACGTC
GATTGTGAAAGCTCGGGGCTTAACCCCGAGTCTGCAGTCGATACGGGCTAGCTAGAG
TGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGA
GGAACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAA
396
100%3
Streptomyces violaceoruber, 98%
Streptomyces
netropsis
AGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAG
M. Deckers, et al. Food Chemistry 305 (2020) 125431
7
verify the absence of ambiguity in the blast results, the first hit to an
incorrect species was also investigated. These results are presented in
Table 2B. For all bacterial species present in the FE list (Table 1),
blasting the generated amplicon sequence against the in-house database
always assigned the correct species as first hit with a percent sequence
identity ranging between 92% and 100% and a query coverage of
100%. Moreover, the percent identity of the first hit corresponding to
the correct species was always higher than the percent identity of their
first incorrect species hit, with the exception of Streptomyces rubiginosus,
B. subtilis and B. licheniformis for which there was no difference between
the percent identity of the correct species and first incorrect species hit,
although the latter one always belonged to the same genus. If an
identification down to the species level is required for these more
problematic species, species-specific PCR methods could be performed
(De Clerck, Van Mol, Jannes, Rossau, & De Vos, 2004). This suggests
that the proposed strategy based on conventional PCR amplification
and sequencing of the 16S-rRNA gene region, allows to identify FE
bacterial strains at least down to the genus level, based on their first hit
in a 16S-rRNA gene region database, for all 29 tested bacterial strains
known to produce FE, and for the majority of cases even down to the
species level. These results were also confirmed through additional
phylogenetic analyses of the obtained 16S-rRNA gene region sequences
(see Section 3.3).
3.3. Assessment of the in-house 16S-rRNA gene region database
The proposed generic strategy based on 16S-rRNA gene region
amplification and Sanger sequencing followed by blasting against a
16S-rRNA gene region database, containing records for all FE producing
bacterial strains, always allowed for the correct identification of the FE
bacterial strain by assignment to the correct species as first hit.
Although the same approach has also been used by others (Fontana,
Favaro, Pelliccioni, Pistoia, & Favalli, 2005), some caution is needed for
the interpretation of the results. In particular, the 16S-rRNA gene re-
gion has low phylogenetic power at the species level and poor dis-
criminatory power for some genera (Mignard & Flandrois, 2006), which
is especially problematic for the genus Bacillus. Within the Bacillus
genus some species display very high sequence similarity in their 16S-
rRNA gene region so that their small 16S-rRNA gene differences cannot
justify choosing the first hit as definitive identification (Janda & Abbott,
2007). Although, the extent of this problematic is considerably reduced
in our case because the identification is limited to 27 of the 30 FE
producing bacterial strains present in the list of 304 dossiers submitted
to EFSA (no Chryseobacterium proteolyticum and Paenibacillus alginoly-
ticus strains were available from public collections and no Pseudomonas
amyloderamosa sequence information is available in our in-house con-
structed database). We performed an additional phylogenetic in-
vestigation to characterize the extent of any such bias that may be
present in our set-up and which is not directly apparent based on results
presented in Table 2. More specifically, we constructed two bootstrap
consensus phylogenetic trees based on all 16S-rRNA gene region se-
quences present in our in-house curated 16S-rRNA gene region data-
base, and the former supplemented with all generated bacterial am-
plicon 16S-rRNA gene region sequences listed in Table 2. The resulting
trees are provided in Supplementary files IV and V, and are presented as
a sunburst chart to simplify their interpretation in Fig. 1. The inner and
outer rings represent all bacterial genera and species, respectively, and
are listed in black in case all their corresponding 16S-rRNA gene region
sequences were unambiguously grouped together in one cluster in the
constructed phylogenetic trees or alternatively in grey if this was not
the case. Fig. 1 illustrates that all 16S-rRNA gene region sequences al-
ways properly clustered down to the correct genus level, and in the
majority of cases (82.2%) also down to the correct species level for the
selected FE bacterial strains with the remaining 17.8% consisting out of
B. subtilis, B. licheniformis, Streptomyces rubiginosus, S. violaceoruber and
S. mobaraensis. Although these results are derived from a limited set of
16S-rRNA gene region sequences obtained specifically from FE produ-
cing bacterial strains, they are in line with general estimates for iden-
tification of bacteria based on 16S-rRNA gene sequencing. Generally,
identification is possible to the genus level (> 90%) and to a lesser
extent to the species level (65%–83%) (Janda & Abbott, 2007), con-
firming that all FE producing bacteria can be identified down to the
genus level with this strategy and the majority also down to the species
level. For the exceptions listed above, although the first hit always
correctly assigned the correct species, a more robust identification
could for instance be obtained using an additional specific (q)PCR
method. For the future development of these (q)PCR methods we will
focus in particular on B. subtilis and B. licheniformis because combined
they account 45.4% of FE produced by bacteria.
3.4. Sensitivity of the strategy on a spiked industrial enzyme sample
The sensitivity of the proposed generic strategy of first line
screening was investigated using an artificially spiked liquid α-amylase
FE preparation, produced by B. licheniformis, one of the most frequent
FE producing organism used in the FE industry, with various con-
centrations (from 9.2 ∗ 105 to 9.2 ∗ 10−3 CFU/DNA extraction) of the
FE producing bacteria to mimic an accidental contamination (Table 1,
Fig. 2). As a control, an isolated colony from the spiked FE preparation
was also submitted to the proposed generic strategy of first line
screening.
First, using the conventional PCR targeting the V3–V4 16S-rRNA
gene regions, no PCR amplicon was observed for the non-spiked FE
preparation while an amplicon of the expected size (417 bp) was ob-
served for the spiked FE preparation up to the dilution D-2, corre-
sponding to 4.6 ∗ 102 CFU (Fig. 2B, Table 2B). The subsequent se-
quencing analysis of the generated amplicons confirmed the
GGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAGAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTTGCGTC
GGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGCAGGCTAGAG
TGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGA
GGAACACCGGTGGCGAAGGCGGATCTCTGGGCCATTACTGACGCTGAGGAGCGAAA
396
100%3
Streptomyces mobaraensis, 98%
Streptomyces
mobaraensis
AGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAG
GGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCGCGTC
GGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGCAGGCTAGAG
TTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAA
396
100%2
Streptomyces rubigiosus, 99%
Streptomyces
rubiginosus
AGCAGTGGGGAATATTGCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAG
GGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGGAAGAAGCGAAAGTGACGG
TACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGG
CGCGAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCGGCTTGTCGCGTC
GGTTGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCAGTCGATACGGGCAGGCTAGAG
TTCGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATATCAGGAG
GAACACCGGTGGCGAAGGCGGATCTCTGGGCCGATACTGACGCTGAGGAGCGAAA
396
99%2
Streptomyces violaceoruber, 99%
a Was not available in the consulted public strain collections.
b The superscript represents the number of sequences that had that specific
percentage as BLAST result available in the in-house database. The expected
strain is the FE producing micro-organism that is analysed and is indicated in
the first column “FE producing bacteria”.
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identification of B. licheniformis (100% sequence identity) (Fig. 2C).
However, it should be noticed that, although this identification analysis
led to the correct species, the discriminatory power of the proposed
strategy only allows a confident identification down to the genus level
(see Fig. 1).
3.5. Applicability assessment of the strategy on commercial FE preparations
The applicability of the proposed generic strategy was analysed on
six commercial FE preparations (Fig. 3A). These commercial FE pre-
parations are produced using bacterial strains (α-amylase from Bacillus
licheniformis and neutral protease from Bacillus subtilis), fungal strains
(lactase from Aspergillus oryzae and microbial rennet from Rhizomucor
miehei) or plants (papain from Papaya). In addition, for one selected FE
preparation (Flour treatment agent) no information regarding the
producing organism(s) is available. The use of the conventional PCR
analysis, targeting the V3–V4 16S-rRNA regions, on the extracted DNA
from the six commercial matrices showed the presence of a PCR am-
plicon of 417 bp for the two FE preparations produced by B. licheni-
formis and B. subtilis while no PCR amplification was observed for the
four other commercial matrices (Table 1, Fig. 3B). These PCR amplifi-
cations demonstrate the presence of DNA from bacteria inside these 2
tested FE preparations. Following to the sequencing of the observed
amplicon for each of these 2 FE preparations, the blast analysis of the
generated sequences against our in-house curated 16S-rRNA gene re-
gion database allowed to identify B. licheniformis (100% sequence
identity) in the α-amylase FE preparation and B. amyloliquefaciens or B.
subtilis (respectively 100% and 99.28% identity) in the neutral protease
FE preparation. The identified bacterial species corresponded to the
mentioned FE producing bacterial species (Fig. 3A and D). The
difficulty of identification down to the species level for B. subtilis was
expected, as previously mentioned in Sections 3.2 and 3.3. These results
therefore illustrate the applicability of the proposed generic strategy of
first line screening on FE preparations.
In addition, for each of the two FE preparations in which bacterial
DNA was detected, the viability status of the identified bacteria was
determined using a classical microbiology analysis. For each of these FE
preparations, living bacterial colonies were observed (Fig. 3C) and
submitted to the proposed generic strategy of first line screening
(Fig. 3D).
The obtained sequencing results of the colony amplicons were similar
to the above mentioned results from the direct DNA extraction of the FE
preparations. These results allow confirming the presence of viable strains
belonging to the Bacillus strains in the tested matrices. The high level of
bacterial contamination combined with the identified bacterial genus
strongly suggest that the FE producing bacterial strains are accidentally
present in these FE preparations. However, environmental microbial
contaminations, which could potentially occur during the fermentation
and packaging processes, cannot be excluded. To confirm the origin of the
contamination, further analysis is thus needed in a second step.
4. Conclusion
In order to allow the detection and identification of accidental
contaminations of the FE producing bacteria in FE preparations, a new
generic strategy of first line screening is proposed using a conventional
PCR approach to amplify 16S-rRNA regions, followed by sequencing for
characterization. The strategy specificity was successfully tested on all
FE producing microbial species mentioned in the 304 FE dossiers sub-
mitted to EFSA. Results from the blast approach of the 16S-rRNA gene
Fig. 1. 16S-rRNA gene region amplification and
Sanger sequencing allows identification of FE bac-
terial strains down to the genus level, and for the
majority of the cases to the species level, for FE
producing bacterial strains. The inner and outer
rings represent all bacterial genera and species,
respectively. Genera and species names are in-
dicated in black if all their 16S rRNA gene region
sequences unambiguously grouped together in one
cluster based on phylogenetic analysis, and in grey
otherwise. Pseudomonas amyloderamosa is indicated
with a white background because no reference 16S
rRNA gene region sequences were available for this
species and therefore did not allow identification.
Chryseobacterium proteolyticum and Paenibacillus
alginolyticus are indicated with a white background
because no bacterial culture was available in the
reference collections.
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region sequences against the constructed in-house 16S-rRNA gene re-
gion database, containing 16S-rRNA reference sequences of FE produ-
cing bacterial species, show the ability to identify all tested FE produ-
cing bacteria at least down to the genus level. This was also confirmed
by additional phylogenetic analyses. Regarding the sensitivity, the
conventional PCR method amplifying the 16-rRNA region was able to
reach an estimated concentration of 460 CFU/reaction. This suggests
that the application of this strategy would be appropriate to detect
contaminations at high levels and to identify the genus/species of iso-
lated bacteria. In order to detect contaminations at lower levels, other
approaches would need to be applied, such as specific qPCR's targeting
genera or species of the FE producing bacterial strains. The applicability
Fig. 2. Overview of the sensitivity assessment of the proposed generic strategy of first line screening.
An α-amylase sample was artificially contaminated with various concentrations of Bacillus licheniformis (indicated by the manufacturer as being the producing
organism of this enzyme preparation).
A: A 10-fold dilution series was performed of a B. licheniformis liquid culture, which was spiked in the liquid α-amylase sample. Both the liquid cultures and the spiked
solutions were analysed using the proposed generic strategy of first line screening. As a control, all dilutions were also plated on NA and the obtained colonies were
analysed using the proposed generic strategy of first line screening.
B: Visualization of the PCR results, representing both the amplifications of the B. licheniformis dilution series and the amplifications of the dilution series artificially
spiked in the α-amylase preparation.
C: The sequences generated using the proposed generic strategy of first line screening applied on the DNA extracted from the B. licheniformis D-0 liquid culture and
from the isolated colony. Both sequences could be identified as B. licheniformis.
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of the proposed generic strategy was also successfully tested using
commercially available FE preparations. These results have allowed to
highlight the contamination of Bacillus species in two FE preparations.
Given that these bacterial species were mentioned as FE producer for
these two FE preparations, these results strongly suggest an accidental
contamination of the FE producing bacterial strains, even though an
environmental microbial contamination cannot be excluded. However,
after this first line screening, additional analyses using or PCR markers,
specific to certain bacterial species and genetically modified organisms,
or whole genome sequencing approaches (Barbau-piednoir, De
Keersmaecker, Delvoye, et al., 2015; Barbau-piednoir, De
Keersmaecker, Wuyts, et al., 2015; Paracchini et al., 2017) would need
to be performed for a deeper characterization and to confirm the pre-
sence of the FE producer micro-organisms, or its corresponding DNA, in
the tested sample. In any case, the results obtained in this study clearly
demonstrate the added value of the proposed generic strategy of first
line screening to detect the accidental contamination of bacteria, ge-
netically modified or not, in FE preparations.
Our proposed new generic strategy, adequate as a first screening to
verify the potential presence of FE producing bacteria, could also be
applied on related microbial fermentation products such as food and
feed additives and flavouring products. However, for such products, it
would be needed to extend the spectra of species specifically used for
their production.
Fig. 3. Overview of the applicability assessment of the proposed generic strategy of first line screening.
A: All tested FE preparations with their corresponding producer organism.
B: Visualization of the generated PCR products from the tested FE preparations.
C: Bacteria viability assessment of the two FE preparations showing a positive PCR amplification (B).
D: Analysis of the generated sequences, of the PCR products from the two FE preparations showing a positive PCR amplification (B) and of the viable colonies
observed in (C).
M. Deckers, et al. Food Chemistry 305 (2020) 125431
11
Declaration of competing interest
The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influ-
ence the work reported in this paper.
Acknowledgements
The research that yielded these results, was funded by the Belgian
Federal Public Service of Health, Food Chain Safety and Environment
through the contract [RT 17/5 SPECENZYM] and by the NRL-GMO
(Sciensano, Belgium).
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.foodchem.2019.125431.
References
Anadón, A., Bell, D., Binderup, M., Bursch, W., Castle, L., Engel, K., … Wölfle, D. (2009).
Guidance of the Scientific Panel of Food Contact Materials, Enzymes, Flavourings and
Processing Aids (CEF) on the submission of a dossier on food enzymes for safety
evaluation by the Scientific Panel of Food Contact Material, Enzymes, Flavourings an,
1305(2009), 1–26.
Barbau-piednoir, E., De Keersmaecker, S. C. J., Delvoye, M., Gau, C., Philipp, P., &
Roosens, N. H. (2015). Use of next generation sequencing data to develop a qPCR
method for specific detection of EU-unauthorized genetically modified Bacillus sub-
tilis overproducing riboflavin. BMC Biotechnology, 15(1), 1–10. https://doi.org/10.
1186/s12896-015-0216-y.
Barbau-piednoir, E., De Keersmaecker, S. C. J., Wuyts, V., Gau, C., Pirovano, W., Costessi,
A., … Roosens, N. H. (2015). Genome sequence of EU-unauthorized genetically
modified Bacillus subtilis strain 2014-3557 overproducing riboflavin, isolated from a
vitamin B2 80% feed additive. Genome Announcements, 3(2). doi:https://doi.org/
10.1128/genomeA.00214-15.
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden,
T. L. (2009). BLAST+: Architecture and applications. BMC Bioinformatics, 10, 421.
https://doi.org/10.1186/1471-2105-10-421.
Cerutti, G., Boudot, J., Bournigal, J.-M., & Rousseau, L. (2006). Arrêté du 19 octobre 2006
relatif à l'emploi d'auxiliaires technologiques dans la fabrication de certaines denrées
alimentaires. Retrieved from https://www.legifrance.gouv.fr/affichTexte.do?
cidTexte=LEGITEXT000020667468#LEGISCTA000020667473.
Commission of the European Communities. (1991). Guidelines for the presentation of
data on food enzymes.
COMMISSION REGULATION (EU) No 231/2012 of 9 March 2012 laying down specifi-
cations for food additives listed in Annexes II and III to Regulation (EC) No 1333/
2008 of the European Parliament and of the Council. (2012). Official Journal of the
European Union (Vol. 22).
De Clerck, E., Van Mol, K., Jannes, G., Rossau, R., & De Vos, P. (2004). Design of a 5′
exonuclease-based real-time PCR assay for simultaneous detection of Bacillus liche-
niformis, members of the “B. cereus group” and B. fumarioli in gelatine. Letters in
Applied Microbiology, 39(1), 109–115. https://doi.org/10.1111/j.1472-765X.2004.
01550.x.
Dorn-In, S., Bassitta, R., Schwaiger, K., Bauer, J., & Hölzel, C. S. (2015). Specific ampli-
fication of bacterial DNA by optimized so-called universal bacterial primers in sam-
ples rich of plant DNA. Journal of Microbiological Methods, 113, 50–56. https://doi.
org/10.1016/j.mimet.2015.04.001.
European Commission. (2016). Food enzyme applications submitted to the Commission
within the legal deadline (from 11 September 2011 to 11 March 2015). Retrieved
from http://oxfordhandbooks.com/view/10.1093/oxfordhb/9780199546282.001.
0001/oxfordhb-9780199546282-e-24.
European Parliament and Council (2008). Regulation (EC) No 1331/2008 of the
European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food flavourings.
Official Journal of the European Union, 354, 16–33. Retrieved from http://eur-lex.
europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:354:0001:0006:EN:PDF.
European Parliament and Council of the European Union. (2008). Regulation (EC) No
1332/2008 of the European Parliament and of the Council of 16 December 2008 on
food enzymes and amending Council Directive 83/417/EEC, Council Regulation (EC)
No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and(..).
Official Journal of the European Union L 354, 51(1332), 7–15.
European Parliament and the Concil of the European Union. (2008). Regulation (EC) No
1333/2008 of the European Parliament ans of the Council of 16 December 2998 on
food additives. Official Journal of the European Union, (L 354), 16–33.
Fontana, C., Favaro, M., Pelliccioni, M., Pistoia, E. S., & Favalli, C. (2005). Use of the
MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates
that commercial automated systems failed to identify correctly. Journal of Clinical
Microbiology, 43(2), 615–619. https://doi.org/10.1128/JCM.43.2.615.
Fraiture, M. A., Herman, P., Taverniers, I., De Loose, M., Deforce, D., & Roosens, N. H.
(2014). An innovative and integrated approach based on DNA walking to identify
unauthorized GMOs. Food Chemistry, 147, 60–69.
Janda, J. M., & Abbott, S. L. (2007). Minireview. 16S rRNA gene sequencing for bacterial
identification in the diagnostic laboratory: Pluses, perils, and pitfalls. Journal of
Clinical Microbiology, 45(9), 2761–2764. doi:https://doi.org/10.1128/JCM.
01228-07.
JEFCA (2006). Compenidum of food additive specifications.
Lebonah, D. E., Dileep, A., Chandrasekhar, K., Sreevani, S., Sreedevi, B., & Kumari, J. P.
(2014). DNA barcoding on bacteria: A review. Advances in Biology, 2014, 9.
Magnuson, B., Munro, I., Abbot, P., Baldwin, N., Lopez-Garcia, R., Ly, K., ... Socolovsky, S.
(2013). Review of the regulation and safety assessment of food substances in various
countries and jurisdictions. Food Additives and Contaminants - Part A Chemistry,
Analysis, Control, Exposure and Risk Assessment, 30(7), 1147–1220. Retrieved from
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&
NEWS=N&AN=2013434205.
Mignard, S., & Flandrois, J. P. (2006). 16S rRNA sequencing in routine bacterial identi-
fication: A 30-month experiment. Journal of Microbiological Methods, 67, 574–581.
https://doi.org/10.1016/j.mimet.2006.05.009.
O'Leary, N. A., Wright, M. W., Brister, J. R., Ciufo, S., Haddad, D., McVeigh, R., ... Pruitt,
K. D. (2016). Reference sequence (RefSeq) database at NCBI: Current status, taxo-
nomic expansion, and functional annotation. Nucleic Acids Research, 44(D1),
D733–D745. https://doi.org/10.1093/nar/gkv1189.
Paracchini, V., Petrillo, M., Reiting, R., Angers-Loustau, A., Wahler, D., Stolz, A., ...
Grohmann, L. (2017). Molecular characterization of an unauthorized genetically
modified Bacillus subtilis production strain identified in a vitamin B2feed additive.
Food Chemistry, 230, 681–689. https://doi.org/10.1016/j.foodchem.2017.03.042.
Pariza, M. W., & Johnson, E. A. (2001). Evaluating the safety of microbial enzyme pre-
parations used in food processing: Update for a new century. Regulatory Toxicology
and Pharmacology, 33(2), 173–186. https://doi.org/10.1006/rtph.2001.1466.
RASFF portal https://webgate.ec.europa.eu/rasff-window/portal/?event=SearchForm&
cleanSearch=1.
Raveendran, S., Parameswaran, B., Ummalyma, S. B., Abraham, A., Mathew, A. K.,
Madhavan, A., … Pandey, A. (2018). Applications of microbial enzymes in food in-
dustry. Food Technology and Biotechnology, 56(1), 16–30. doi:10.17113/ftb.56.01.
18.5491.
Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25
November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the
European Parliament and of the Council and repealing Regulation (EC) No 258/97 of
the European Parliament and of the Council and Commission Regulation (EC) No
1852/2001 (text with EEA relevance).
Ricci, A., Allende, A., Bolton, D., Chemaly, M., Davies, R., Girones, R., … Salvador, P.
(2017). Scientific opinion on the update of the list of QPS-recommended biological
agents intentionally added to food or feed as notified to EFSA * (Vol. 15). doi:https://
doi.org/10.2903/j.efsa.2017.4664.
Rozwandowicz, M., Brouwer, M. S. M., Fischer, J., Wagenaar, J. A., Gonzalez-Zorn, B.,
Guerra, B., ... Hordijk, J. (2018). Plasmids carrying antimicrobial resistance genes in
Enterobacteriaceae. Journal of Antimicrobial Chemotherapy, 73(5), 1121–1137.
https://doi.org/10.1093/jac/dkx488.
Rychen, G., Aquilina, G., Azimonti, G., Bampidis, V., Bastos, M. D. L., Bories, G., ...
Galobart, J. (2018). Guidance on the characterisation of microorganisms used as feed
additives or as production organisms, 16(February), 1–24. https://doi.org/10.2903/j.
efsa.2018.5206.
Singh, R., Kumar, M., Mittal, A., & Kumar, P. (2016). Microbial enzymes: Industrial
progress in 21st century. 3. Biotech, 6(2), 1–15. https://doi.org/10.1007/s13205-
016-0485-8.
Spök, A. (2006). Safety regulations of food enzymes. Food Technology and
Biotechnology, 44.
Srinivasan, R., Karaoz, U., Volegova, M., MacKichan, J., Kato-Maeda, M., Miller, S., ...
Lynch, S. V. (2015). Use of 16S rRNA gene for identification of a broad range of
clinically relevant bacterial pathogens. PLoS One, 10(2), 1–22. https://doi.org/10.
1371/journal.pone.0117617.
Standing Committee on the Food Chain and Animal Health. (2005). Section on genetically
modified food and feed. https://ec.europa.eu/food/sites/food/files/plant/docs/sc_
modif-genet_summary02_en.pdf.
West-Barnette, S., & Srinivasan, J. R. (2013). Manufacturing process and composition. In
P. M. Visakh, S. Thomas, L. B. Iturriaga, & D. R. Pablo (Eds.), Advances in food
science and technology (pp. 219–222).
Xiong, W., Wang, Y., Sun, Y., Ma, L., Zeng, Q., Jiang, X., ... Zhang, T. (2018). Antibiotic-
mediated changes in the fecal microbiome of broiler chickens define the incidence of
antibiotic resistance genes. Microbiome, 6(1), 34. https://doi.org/10.1186/s40168-
018-0419-2.
M. Deckers, et al. Food Chemistry 305 (2020) 125431
12
